Jin-ping Li

Title: The Innovations of Jin-ping Li

Introduction

Jin-ping Li is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of biotechnology, holding a total of three patents. His work focuses on advancements that have the potential to impact therapeutic drug development and enzyme production.

Latest Patents

One of Jin-ping Li's latest patents is related to "Heparanase deficient non-human mammals." This invention pertains to cells and transgenic non-human mammals that possess at least one disrupted heparanase allele. The invention also includes methods for screening therapeutic drug candidates using these heparanase deficient non-human mammals and cells. Another significant patent is for "Glucuronyl C5-epimerase, DNA encoding the same and uses thereof." This invention introduces a novel purified mouse C5-epimerase, along with its fragments and nucleic acids. It also discusses the recombinant production of this epimerase and its fragments, particularly N-terminal fragments that can enhance the activity of recombinantly-produced heterologous epimerase enzymes.

Career Highlights

Throughout his career, Jin-ping Li has worked with various companies, including Biotie Therapies Corporation and Inalco S.p.a. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Jin-ping Li has collaborated with notable colleagues such as Ulf Lindahl and Markku Jalkanen. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Jin-ping Li's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic drug development and enzyme technology.